| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
disease | 0.140 | None | 1.000 | 3 | 0 | 2003 | 2019 | ||||||||
|
adenosine deaminase | 0.440 | 0.885 | 2.9E-12 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
recombination activating 2 | 0.507 | 0.769 | 2.0E-02 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
caspase 10 | 0.528 | 0.692 | 4.6E-12 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
CD47 molecule | 0.468 | 0.769 | 0.92 |
|
disease | 0.040 | None | 0.750 | 3 | 0 | 2004 | 2009 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.030 | None | 1.000 | 2 | 0 | 2002 | 2019 | ||||||||
|
keratin 20 | 0.388 | 0.846 | 9.1E-11 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2000 | 2020 | ||||||||
|
immunoglobulin heavy variable 3-69-1 (pseudogene) | 0.561 | 0.654 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2013 | |||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | ||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2019 | ||||||||
|
haptoglobin | 0.412 | 0.885 | 1.7E-05 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2010 | 2017 | ||||||||
|
immunoglobulin heavy locus | 0.473 | 0.654 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2013 | |||||||||
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene) | 0.566 | 0.654 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2013 | |||||||||
|
Fc fragment of IgG receptor IIIb | 0.452 | 0.962 | 3.0E-07 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1998 | 2017 | ||||||||
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 | 0.527 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2013 | |||||||||
|
RNA, 7SL, cytoplasmic 263, pseudogene | 0.496 | 0.808 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2017 | |||||||||
|
Fc fragment of IgG receptor IIIa | 0.432 | 0.962 | 3.7E-06 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1998 | 2017 | ||||||||
|
immunoglobulin heavy variable 4-38-2-like | 0.514 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2013 | |||||||||
|
membrane spanning 4-domains A1 | 0.411 | 0.846 | 5.1E-05 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2000 | 2020 | ||||||||
|
signal regulatory protein alpha | 0.592 | 0.769 | 0.67 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2004 | 2009 | ||||||||
|
survival of motor neuron 1, telomeric | 0.454 | 0.769 | 1.6E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
solute carrier family 4 member 1 (Diego blood group) | 0.522 | 0.731 | 0.85 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
IgA nephropathy | 0.524 | 0.808 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
Rh blood group D antigen | 0.612 | 0.654 | 2.9E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
RAS p21 protein activator 1 | 0.481 | 0.885 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 |